I think we were all fooled by the pr saying something like - " come to the big celebration after the late breaker is released at this prestigious event, all investors invited to the champagne party in Amsterdam" .........
40 institutions sold out, end of second quarter. Amgen had results, end of May, early June ? Retail investors like us, the last to know. Word got out to big money , primary endpoint missed ? Short interest was 200k in April, 1.7 million 8/15 - will be interesting to see Sept 1st short interest. Over 2 mill ?
Late breaker abstract , with failed primary endpoint - another lesson,,,, a few more like this ,,,,,,,,,,,, any good mutual funds out there - ha.
Absolutely ...really disappointed in management ...to the point that I feel like they failed in their fudicary duty. I bought 1000 shares in the last 40 days ...avg 12 dollars ....12 grand that is now heading to 7 grand
You banged the nail right on the head daweasel. CYTK tried to create optics to create excitement and reinforce their view of a successful trial. Many CV medicines efficacy is dose related, cardizem, digitalis, ACEI's, ARB's, diuretics. Nothing new here, but any reason to short.